To test the hypothesis that Oct1 loss can accelerate tumor initiation in models of malignancy dependent on mitotic errors and LOH, we used conditional deletion of the Apc gene, which is mutated in a large proportion of human colon cancers [47]. The gene discussed is APC; the disease is colonic neoplasm.